Take your health into your own hands

Take your health into your own hands

Take your health into your own hands

Spontaneous chronic urticaria

Pomphi, itching (often nocturnal) and swelling of certain parts of the body, sometimes disfiguring, with no known cause and disappearing only to recur suddenly and unpredictably. These are the symptoms of the chronic spontaneous urticaria, a particular form of urticaria unrelated to allergic factors that mainly affects individuals between the ages of 20 and 40 years (women twice as frequently), though it can appear at any time of life, and lasts on average for 3-4 years but sometimes even for decades. Although it affects 1 percent of the population, it is underestimated in both frequency and impact, leading to repercussions on school and work performance, social relationships, and psychological well-being.

This problem negatively affects quality of life to a greater extent than patients with even more serious skin problems, such as psoriasis. The presence of autoimmune diseases, especially thyroid disease, such as Hashimoto’s thyroiditis present in 10% of cases, celiac disease, and type 1 diabetes appears to correlate with an increased risk of chronic spontaneous urticaria. For the reasons explained above, it is easy to see why recognition of the disease is often delayed.

Diagnosis and treatment

The diagnostic pathway first proceeds with the search for any pathology associated with urticaria. Second step is to try to avoid factors that can aggravate urticaria, such as stress and especially the use of nonsteroidal anti-inflammatory drugs capable of inducing a flare-up or aggravation of urticaria in 20-30% of patients. The pharmacological approach involves the use of second-generation antihistamines at standard dosage, which can be doubled or quadrupled if symptoms persist after 2-4 weeks of therapy.

As a next step, omalizumab, a biologic drug that can improve symptoms in many cases and probably change the course of the disease, is used. If necessary, the fourth line of treatment relies on immunosuppressants, such as cyclosporine A, and the fifth on montelukast, an antileukotrienic. Unlike other chronic diseases, there is still no national patient registry and an organized network of services, and there are still numerous interregional disparities and limits to the Health Service’s coverage of treatment with antihistamines (in fact, they are reimbursed only at the standard dosage) and omalizumab, which is provided in the treatment plan for only 6 months.

NUTRITION AND DIET
 
NATURE, SPORTS, PLACES
 
CULTIVATING HEALTH
 
MENOPAUSE
 
MOM IN SHAPE
 
TRADITIONAL CHINESE MEDICINE
 
HEART SURGERY
 
MEDICINES AND MEDICAL DEVICES
 
PARENTING
 
THE CULTURE OF HEALTH
 
HEALTH UTILITIES
 
GENERAL MEDICINE
 
NATURAL MEDICINE, THERMAL
 
MIND AND BRAIN
 
NEUROVEGETATIVE DYSTONIA
 
WAYS OF BEING
 
HEALTH AND SOCIETY
 
HEALTHCARE AND PATIENTS
 
SEXUALITY
 
OLDER AGE
 
CANCERS
 
EMERGENCIES
 
NUTRITION AND DIET
 
NATURE, SPORTS, PLACES
 
CULTIVATING HEALTH
 
MENOPAUSE
 
MOM IN SHAPE
 
TRADITIONAL CHINESE MEDICINE
 
HEART SURGERY
 
MEDICINES AND MEDICAL DEVICES
 
PARENTING
 
THE CULTURE OF HEALTH
 
HEALTH UTILITIES
 
GENERAL MEDICINE
 
NATURAL MEDICINE, THERMAL
 
MIND AND BRAIN
 
NEUROVEGETATIVE DYSTONIA
 
WAYS OF BEING
 
HEALTH AND SOCIETY
 
HEALTHCARE AND PATIENTS
 
SEXUALITY
 
OLDER AGE
 
CANCERS
 
EMERGENCIES
 
DIGESTIVE SYSTEM
 
RESPIRATORY SYSTEM
 
UROGENITAL SYSTEM
 
HEART AND CIRCULATION
 
SKIN
 
INFECTIOUS DISEASES
 
EYES
 
EARS, NOSE, AND THROAT
 
BONES AND LIGAMENTS
 
ENDOCRINE SYSTEM
 
NERVOUS SYSTEM
 
DIGESTIVE SYSTEM
 
RESPIRATORY SYSTEM
 
UROGENITAL SYSTEM
 
HEART AND CIRCULATION
 
SKIN
 
INFECTIOUS DISEASES
 
EYES
 
EARS, NOSE, AND THROAT
 
BONES AND LIGAMENTS
 
ENDOCRINE SYSTEM
 
NERVOUS SYSTEM
 

your advertising
exclusively ON
MY SPECIAL DOCTOR

complete the form and you will be contacted by one of our managers